Fuda Cancer Hospital - Malaysia

Fuda Cancer Hospital - Malaysia Fuda is committed to providing cancer patients around the world with the best medical care. There are totally 400 beds, of which 45 are VIP wards .
(2)

Located in Tianhe District (North Campus) and Haizhu District (South Campus) of Guangzhou City, Fuda Cancer Hospital is under the jurisdiction of Health supervision bureau of Guangdong Province, a bureau that mostly regulates government founded hospitals. Fuda is an affiliated hospital to Jinan University and is the Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of

Chinese Academy of Sciences. Fuda operates under the international standards, and was selected as the National Key Clinical Speciality hospital (Oncology) in 2010. Fuda has several highly efficient and professional teams: cryosurgical ablation team, micro-vascular intervention team, immunotherapy team, surgical teams for head-neck, chest and a team for hepato-biliary cancer. The Joint Commission International (JCI), one of the most widely recognized hospital evaluation system, accredited Fuda Cancer Hospital in 2013. In Fuda, we value technology, integrity and humanity. Life is what we hold dear here. Fuda has been providing patients around the world with high-tech, world-class medical services. With all the miracles and success made in the past decade, Fuda is striving to reach the ultimate goal to become a hospital that is specialized in most novel cancer treatment, equipped with advanced medical instrument and focuses on cutting-edge oncological science. In the past decade, Fuda has been using latest cancer-treating technologies to treat patients who were in early or advanced stage of cancer. Fuda's treatment has helped patients by significantly prolonging patient’s survival time and improving life quality. Fuda has developed a unique “3C+P” treatment model, which is, cryosurgical ablation (CSA), CANCER MICRO-VASCULAR INTERVENTION (CMI), COMBINED IMMUNOTHERAPY FOR CANCER (CIC), AND PERSONALIZED TREATMENTS (P). So far, Fuda has had more than 10,000 cases of cryosurgical ablation, which ranks No.1 in the world in terms of quantity as well as the types of cancer treated. Fuda has attracted cancer patients from more than 70 countries around the world, 70 percent of patients from foreign countries in South-East Asia, the Middle East, Oceanic, Europe and North America. Fuda has received various awards in China and abroad for outstanding achievements in treating cancer and been highly praised by patients around the world.

28/05/2026

[Minimally Invasive Treatment] [lung cancer – cryoablation]
>>>Visual Navigation Cryoablation for Lung Tumors> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

[Fuda News | World Ablative Therapies Association (WATA 2026)]Global Ablation Experts Gather as Fuda Shines at WATA 2026...
28/05/2026

[Fuda News | World Ablative Therapies Association (WATA 2026)]
Global Ablation Experts Gather as Fuda Shines at WATA 2026
From May 15 to 17, 2026, the inaugural academic conference of the World Ablative Therapies Association (WATA 2026) was held in Beijing, China.

As WATA’s first global academic event, the conference was themed “United in Ablation Worldwide: Building Consensus, Advancing Evidence, Pursuing Excellence.” Leading experts and scholars from more than 30 countries and regions gathered to discuss clinical topics, technological innovation, and discipline development in tumor ablation, while exploring the latest advancements and future directions of ablation therapy.
On May 15, the pre-conference international training courses officially kicked off, focusing on key topics including lung tumor ablation, thyroid tumor ablation, irreversible electroporation (NanoKnife), and liver tumor ablation. Guangzhou Fuda Cancer Hospital President Niu Lizhi was invited to attend and delivered two keynote presentations: Standardization and Techniques of Cryoablation for Liver Cancer and Clinical Application of NanoKnife for Liver and Pancreatic Tumors Under Combined Ultrasound and CT Guidance.

During the training sessions, President Niu shared extensive clinical experience through numerous classic cases, explaining both the technical essentials and clinical challenges of various ablation procedures in a clear and practical manner. Particularly noteworthy was the internationally pioneered “two-needle technique” for NanoKnife ablation developed by Fuda, which received high praise from attending experts and scholars for its cost-effectiveness, safety, and efficiency.

At the Breast and Gynecologic Ablation Session, Ma Yangyang delivered a special presentation titled Cryoablation for Breast Cancer. He noted that compared with traditional open surgery, cryoablation offers several advantages, including minimal trauma, faster recovery, repeatability, real-time imaging guidance, and better cosmetic preservation of the breast.
For carefully selected patients with early-stage breast cancer, as well as those with recurrent or metastatic disease or patients unable to tolerate surgery, cryoablation can serve as an important complementary approach for local tumor control and multidisciplinary treatment.

Importantly, cryoablation is not only a local treatment modality but may also activate anti-tumor immune responses through mechanisms such as tumor antigen release, immunogenic cell death, and modulation of the tumor microenvironment. As a result, the combination of cryoablation with systemic therapies — including immunotherapy, targeted therapy, endocrine therapy, and chemotherapy — is emerging as a promising direction in comprehensive breast cancer treatment. In his presentation, Director Ma also highlighted the value of cryoablation in local tumor control, symptom relief, synergistic multidisciplinary treatment, and potential immune activation based on recent research findings and clinical experience.

As a global academic organization initiated by Chinese physicians, WATA 2026 brought together leading ablation experts from around the world in Beijing, creating a high-level international platform for academic exchange and collaboration. Experts shared their practical experience and unique insights, and the cross-border exchange of ideas greatly benefited all participants.
Notably, the conference also officially designated May 16 as “World Ablation Day” for the first time, marking a new milestone in the global development of ablation therapy in the fight against cancer.
Guangzhou Fuda Cancer Hospital has long been dedicated to the field of minimally invasive cancer therapy. By actively participating in this international conference and sharing China’s experience in tumor ablation, the hospital once again demonstrated its professional expertise and commitment in the field of ablation therapy.
Taking this conference and the newly established “World Ablation Day” as a new starting point, the hospital will continue to strengthen international collaboration, integrate global expertise, and work together with peers worldwide to promote the future development of minimally invasive ablation therapy toward greater precision, standardization, and innovation.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

🇲🇾 马来西亚肿瘤患者专属福利｜无需远赴中国，即可连线中国权威专家如果您或家人正面对胰腺癌、肝癌、肺癌、肾癌等实体肿瘤，想了解国际前沿的微创治疗方式，却不想长途奔波——现在，广州复大肿瘤医院牛立志院长，特别为马来西亚患者开设 专属视频咨询通...
20/05/2026

🇲🇾 马来西亚肿瘤患者专属福利｜无需远赴中国，即可连线中国权威专家

如果您或家人正面对胰腺癌、肝癌、肺癌、肾癌等实体肿瘤，想了解国际前沿的微创治疗方式，却不想长途奔波——现在，广州复大肿瘤医院牛立志院长，特别为马来西亚患者开设 专属视频咨询通道，让您在家即可获得中国顶级专家的一对一诊疗建议。

👨‍⚕️ 咨询专家：牛立志 院长
广州复大肿瘤医院院长
第23届国际冷冻治疗学会主席
暨南大学博士生导师，实体肿瘤微创消融治疗领域权威专家
累计完成超20,000例复杂微创冷冻治疗，发表论文300余篇（含SCI论文81篇）

📞 视频咨询核心福利（马来西亚患者专享）
✅ 每周一 14:30–16:30，15分钟一对一视频沟通，量身定制治疗方案
✅ 提供近3个月内影像及报告即可预约，专家团队初步评估治疗适配性
✅ 马来西亚公民入境中国免签30天，无需额外办理签证，出行更省心
✅ 提供机场接送、全程中英文医疗翻译，就医过程无缝衔接
✅ 大部分商业保险可报销，详情请向您的保险公司确认
💡 特色微创疗法：纳米刀消融、氩氦刀冷冻消融、血管介入等，创伤小、恢复快，替代传统开刀痛苦

📍 广州复大肿瘤医院 吉隆坡办事处
地址：Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang, Kuala Lumpur

#马来西亚肿瘤治疗 #牛立志院长 #肿瘤微创治疗 #海外就医 #复大医院 #癌症咨询 #肿瘤治疗 #中国肿瘤治疗权威专家

Malaysia Cancer Patients – Consult a Top Chinese Expert From HomeFacing pancreatic, liver, lung, or kidney cancer?Get ex...
20/05/2026

Malaysia Cancer Patients – Consult a Top Chinese Expert From Home

Facing pancreatic, liver, lung, or kidney cancer?
Get expert minimally invasive treatment advice at home.

👨‍⚕️ Prof. Niu Lizhi
Presideng, Guangzhou Fuda Cancer Hospital
President, International Society of Cryosurgery
20,000+ cryotherapy procedures, 300+ papers

📞 Exclusive for Malaysia (Video Consultation)
✅ 15-min 1-on-1 with Prof. Niu (Mon, 2:30–4:30 PM)
✅ Free pre-assessment with recent reports/scans
✅ 30-day visa-free to China
✅ Airport transfer & medical translation
✅ Most insurance accepted

📍 FUDA KL Service Centre
Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang, Kuala Lumpur

19/05/2026

Patient Story] [Malaysian-Smarca4 – Interventional Chemotheray]
>>>Given Just 3 Months to Live: Malaysian Woman with Rare Lung Cancer Defies the Odds> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

[Fuda News | 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Radiology (ESTIR)]...
16/05/2026

[Fuda News | 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Radiology (ESTIR)]
President Niu Lizhi Speaks at ESTIR, Showcasing Chinese Healthcare Along the Belt and Road
From May 10 to 11, the 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Radiology (ESTIR) was successfully held in Cairo, the capital of Egypt. Leading experts from various medical fields gathered to exchange cutting-edge research findings and promote the advancement of clinical practice.

Niu Lizhi, President of Guangzhou Fuda Cancer Hospital, was invited to attend the conference and delivered two keynote presentations on “Cryoablation for Lung Cancer” and “Clinical Applications and Advances in Cryoablation.”

Drawing on extensive clinical experience and detailed data, President Niu systematically explained the significant advantages of cryoablation in the treatment of lung cancer and shared practical solutions to common challenges encountered during procedures. He noted that cryoablation offers multiple benefits, including minimal trauma, reduced bleeding, shorter treatment duration, and faster recovery. In addition, the technique can stimulate systemic immune responses and is applicable to nearly all types of solid tumors, demonstrating broad clinical potential.

Notably, just one month earlier, President Niu had also been invited to speak at Egypt’s National Liver Cancer Conference, where he delivered a presentation titled “Cryoablation for Liver Cancer,” which was highly praised by Egyptian medical professionals.

His invitation to once again participate in a major interventional medicine conference in Egypt highlights China’s growing international influence in the field of tumor cryoablation. Today, an increasing number of countries are introducing and promoting this technology, and China has undoubtedly become one of the global leaders in this field. Chinese medical technologies and equipment are now emerging as a shining symbol of China’s contribution to the Belt and Road Initiative.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +6 019 616 4656
🌍 Website: https://en.fudahospital.com/

15/05/2026

atient Story] [Russian-pancreatic cancer – Interventional Chemotheray]
>>>Long Waits for Chemo: Russian Patient Finds Hope in Fuda> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

【Fuda News | Academic Exchange】Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation Successfully Held in Fuda...
15/05/2026

【Fuda News | Academic Exchange】
Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation Successfully Held in Fuda
On April 28, 2026, the Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation was successfully held at Guangzhou Fuda Cancer Hospital. Experts and scholars from institutions including Prince of Wales Hospital Hong Kong, Princess Margaret Hospital Hong Kong, Guangdong Second Provincial General Hospital, Guangdong Provincial People’s Hospital, and The First Affiliated Hospital of Guangzhou Medical University attended the event.

In the morning, the Hong Kong expert delegation arrived at the hospital and conducted on-site observation and academic exchanges in the treatment center. By observing cryoablation procedures for tumors in the liver, lungs, kidneys, and adrenal glands, the experts gained a close-up understanding of the clinical applications of this technology at our hospital and across mainland China. During the session, both sides engaged in in-depth discussions on key topics such as procedural techniques, standardized workflows, and complication prevention and management, laying a solid practical foundation for further academic collaboration. The Hong Kong experts were highly impressed by the hospital’s efficiency and extensive clinical experience, remarking, “Completing seven procedures in one morning is truly impressive — both highly efficient and rich in experience.”

△Academic Session Opens with Expert Insights
In the afternoon, the academic lecture session officially began. At the opening ceremony, Chairman Zhao Jun extended a warm welcome to all attending experts and briefly introduced the hospital’s development achievements. He noted that Guangzhou Fuda Cancer Hospital is a National Clinical Key Specialty Hospital (Oncology) and a national-level “Little Giant” enterprise specializing in innovation and advanced technologies. Over the past two decades, the hospital has provided high-quality medical services to patients from more than 120 countries and regions worldwide.
Chairman Zhao emphasized that under the leadership of President Niu Lizhi, the hospital’s cryoablation technology has gained wide recognition from both domestic and international peers as well as patients. The hospital has also established a dedicated Lung Nodule Diagnosis and Treatment Center, accumulating extensive clinical experience in the management of lung cancer and pulmonary nodules. He expressed hope that this exchange would spark meaningful academic dialogue and further advance cryoablation technology and cancer prevention and treatment efforts.

In his speech, President Niu Lizhi stressed that medicine requires lifelong learning and continuous academic exchange. He noted that only through diverse perspectives and intellectual discussion can medical technologies continue to improve. He stated that the visit of the Hong Kong expert delegation reflected the medical community’s recognition of the hospital’s clinical work. He also expressed hope that both sides would deepen academic cooperation, exchange clinical experience and treatment strategies, and work together to improve cancer care and provide better medical services for patients.

Drawing on extensive clinical cases and detailed data, President Niu systematically explained the significant advantages of cryoablation in the treatment of lung cancer and pulmonary nodules. He also proposed practical solutions to common technical challenges encountered during procedures. According to President Niu, cryoablation may additionally stimulate systemic immune responses, and when combined with immunotherapy, could potentially achieve even better clinical outcomes.

Professor Chen Yanwei from the Department of Pulmonary and Critical Care Medicine at The First Affiliated Hospital of Guangzhou Medical University shared several representative cases involving elderly patients, patients with underlying diseases such as atrial fibrillation, as well as small or anatomically challenging pulmonary nodules. His presentation demonstrated the advantages of cryoablation, including excellent visualization, absence of thermal damage, and good patient tolerance. For lesions located in particularly difficult areas such as near the ventricles or mediastinum, the use of percutaneous robotic-assisted puncture significantly reduced procedural difficulty and enhanced treatment safety.

△In-Depth Case Discussions Promote Consensus
During the case discussion session, experts from both sides conducted in-depth exchanges on several representative cases presented by the Hong Kong delegation. Topics included the feasibility of ablation, selection of ablation methods, and optimal needle placement strategies. The discussions were lively and highly interactive, with many valuable consensus points reached through professional dialogue.
This Guangdong–Hong Kong expert exchange not only deepened mutual understanding between specialists from both regions in the field of lung cancer cryoablation, but also effectively promoted experience sharing and collaborative development. More importantly, it laid a solid foundation for enhancing cancer diagnosis and treatment capabilities together and ultimately benefiting more patients.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

15/05/2026

[Minimally Invasive Treatment] [pancreatic cancer – Nanoknife]
>>>‘Sculpting Ablation’: Nanoknife Ablation For Pancreatic Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +0196164656
🌟 WhatsApp: +0196164656
🌍 Website: https://en.fudahospital.com/

Address

Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang
Kuala Lumpur
50450

Telephone

+60199964656

Website

,

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - Malaysia:

Shortcuts

Share

Category